SCHEMBL19457358

SCHEMBL19457358

C=CC(=O)Nc1ccc(S(=O)(=O)c2cccc(C)c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 9/20 0.61
ABCC9 O60706 1/20 0.59
ABCC8 Q09428 1/20 0.59
KCNJ11 Q14654 1/20 0.59
KCNJ8 Q15842 1/20 0.59
TGM2 P21980 4/20 0.58
F13A1 P00488 1/20 0.51
TGM1 P22735 1/20 0.51
ALDH1A1 P00352 2/20 0.49
MAPT P10636 1/20 0.49
CRHBP P24387 1/20 0.49
CRHR2 Q13324 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
PKM P14618 1/20 0.49
HDAC1 Q13547 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
LMNA P02545 1/20 0.48
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19457356 0.90 SMN1; SMN2 (0.54) NAMPTABCC9ABCC8KCNJ11KCNJ8
SCHEMBL19457350 0.86 TGM2 (0.56) NAMPTABCC9ABCC8KCNJ11KCNJ8
SCHEMBL19457348 0.86 TGM2 (0.77) TGM2F13A1TGM1ALDH1A1MAPT
SCHEMBL20885061 0.83 NAMPT (0.64) NAMPTTGM2F13A1TGM1
SCHEMBL20885062 0.83 TGM2 (0.55) NAMPTTGM2F13A1TGM1SMN1; SMN2
SCHEMBL28177667 0.82 ABCC9 (0.63) NAMPTABCC9ABCC8KCNJ11KCNJ8
SCHEMBL11664189 0.78 ABCC9 (0.59) NAMPTABCC9ABCC8KCNJ11KCNJ8
SCHEMBL7894169 0.78 TGM2 (0.66) TGM2F13A1TGM1MAPTLMNA
SCHEMBL20885055 0.78 SMN1; SMN2 (0.49) NAMPTTGM2F13A1TGM1ALDH1A1
SCHEMBL20885070 0.78 LMNA (0.56) NAMPTTGM2ALDH1A1MAPTCRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3440084-B1 PYRIMIDO-DIAZEPINONE KINASE SCAFFOLD COMPOUNDS AND METHODS OF TREATING PI3K-MEDIATED DISORDERS DANA FARBER CANCER INST INC (US) 2022-12-21 EP disclosed
WO-2017177092-A1 PYRIMIDO-DIAZEPINONE KINASE SCAFFOLD COMPOUNDS AND METHODS OF TREATING PI3K-MEDIATED DISORDERS DANA-FARBER CANCER INSTITUTE, INC. (US) 2017-10-12 WO disclosed